Gskvx000000025896

4 trials 3 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

0 Completed trials

1 Sponsors

10 Countries

Phase III

Phase III: 4

Sponsors using this IMP

GlaxoSmithKline Biologicals 4

All trials

4 total

A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine when Given to Healthy Children 3 Month… Not authorised

2024-516635-27-00 Phase III 2 countries GlaxoSmithKline Biologicals
A study on the immune response and safety of an investigational chickenpox vaccine and a marketed measles, mumps and rubella vaccine when ad… Recruiting

2024-518840-18-00 Phase III 8 countries GlaxoSmithKline Biologicals
A study on the immune response and safety of an investigational chickenpox vaccine when given to healthy children 12 to 15 months of age. Recruiting

2024-515869-33-00 Phase III 4 countries GlaxoSmithKline Biologicals
A study on the safety of an investigational chickenpox vaccine, when given to healthy children, 12 to 15 months of age. Recruiting

2024-515868-31-00 Phase III 5 countries GlaxoSmithKline Biologicals

Showing 1–4 of 4 trials

← All drugs A–Z